In rodent models of Alzheimer’s disease, treatment with SGLT-2 inhibitors such as empagliflozin and dapagliflozin showed significant improvements in memory and learning abilities [50]. The gene discussed is SLC5A2; the disease is early-onset autosomal dominant Alzheimer disease.